This is what I like
Pre-Covid, over 200,000 people were estimated to be living with PF in the US, with
approximately 50,000 new cases diagnosed each year and as many as 40,000 deaths
per year14. The full impact of chronic pulmonary fibrosis associated with the SARSCoV-2 virus on the overall prevalence of PF is yet to be determined.
- Forums
- ASX - By Stock
- PAR
- Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS
Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-14
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $78.73M |
Open | High | Low | Value | Volume |
22.0¢ | 22.5¢ | 22.0¢ | $34.69K | 154.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28174 | 0.225 |
7 | 211158 | 0.220 |
10 | 205052 | 0.215 |
12 | 169584 | 0.210 |
8 | 175200 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 25000 | 1 |
0.235 | 42540 | 3 |
0.240 | 93500 | 3 |
0.245 | 1000 | 1 |
0.250 | 89857 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online